Global Hemostatic Gel Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Hemostatic Gel Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Hemostatic gel is used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.In recent years, global hemostatic gels have developed rapidly, with an average growth rate of around 7%.In 2018, global production of hemostatic gels was about 3.26 million pieces.In 2018, China accounted for about 3 percent of global sales.In the next five years, China's hemostatic gel products will continue to grow rapidly.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Baxter, J&J, CryoLife, Integra Life Sciences are major suppliers.These suppliers have mastered key technologies and patents, and have a fixed customer base, which has formed a monopoly situation in the market.The growth of the elderly population and the increasing prevalence of chronic diseases are the driving factors affecting the industry.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually led to surgery, which in turn spurred the development of the hemostatic gel industry.
Hemostatic Gel report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hemostatic Gel market is projected to reach US$ 1356.5 million in 2034, increasing from US$ 947.3 million in 2022, with the CAGR of 5.2% during the period of 2024 to 2034. Demand from Minimally Invasive Surgery and General Surgery are the major drivers for the industry.
Global Hemostatic Gel key players include Baxter, J&J, Advance Medical Solution, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share over 60%, followed by Europe, with a share over 20 percent.
In terms of product, Fibrin is the largest segment, with a share over 35%. And in terms of application, the largest application is Minimally Invasive Surgery, followed by General Surgery, etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hemostatic Gel market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Baxter
J&J
CryoLife
Integra Life Sciences
Advance Medical Solution
BD
CSL Behring
Pfizer
B Braun
Segment by Type
Fibrin
Gelatin
Other
Minimally Invasive Surgery
General Surgery
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Hemostatic Gel market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hemostatic Gel, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hemostatic Gel industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hemostatic Gel in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hemostatic Gel introduction, etc. Hemostatic Gel Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Hemostatic Gel market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Hemostatic Gel report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hemostatic Gel market is projected to reach US$ 1356.5 million in 2034, increasing from US$ 947.3 million in 2022, with the CAGR of 5.2% during the period of 2024 to 2034. Demand from Minimally Invasive Surgery and General Surgery are the major drivers for the industry.
Global Hemostatic Gel key players include Baxter, J&J, Advance Medical Solution, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share over 60%, followed by Europe, with a share over 20 percent.
In terms of product, Fibrin is the largest segment, with a share over 35%. And in terms of application, the largest application is Minimally Invasive Surgery, followed by General Surgery, etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hemostatic Gel market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Baxter
J&J
CryoLife
Integra Life Sciences
Advance Medical Solution
BD
CSL Behring
Pfizer
B Braun
Segment by Type
Fibrin
Gelatin
Other
Segment by Application
Minimally Invasive Surgery
General Surgery
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Hemostatic Gel market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hemostatic Gel, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hemostatic Gel industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hemostatic Gel in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hemostatic Gel introduction, etc. Hemostatic Gel Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Hemostatic Gel market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices